UBS Group »

Vaccinex shares owned by UBS Group

Quarter-by-quarter ownership of Vaccinex shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Vaccinex

Tip: Access up to 7 years of quarterly data

All positions including Vaccinex held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaccinex by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $224 339 0.66
2023-09-30 $14k 13k 1.13

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Vaccinex

AIGH Capital Management
Worth Venture Partners
Vanguard Group
Two Sigma Investments
UBS Group
Royal Bank of Canada
Advisor Group Holdings
Wells Fargo & Company
Jpmorgan Chase & Co
Bank of America Corporation

View all funds holding Vaccinex